Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-09-16 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, vesting conditions, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of 'Share Issue/Capital Change' (SHA) in the provided classification schema.
2025-09-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고 정정신고' (Amendment to the Report on Granting Stock Options). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the number of shares. This type of filing is a standard corporate disclosure regarding capital structure and equity-based compensation, which falls under the 'Regulatory Filings' category as it is a specific statutory disclosure required by the Financial Supervisory Service/Korea Exchange.
2025-09-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Amendment Report). It details changes to previously granted stock options, including adjustments to the number of recipients and the total number of shares. This type of disclosure regarding capital structure and equity-based compensation falls under the category of regulatory filings for corporate actions that do not fit into specific financial reporting categories like 10-K or ER.
2025-09-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details the granting of stock options to employees, including the number of shares, exercise conditions, and valuation methods. This type of disclosure regarding stock option grants and their subsequent corrections falls under the category of regulatory filings related to capital and share-based compensation, which is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like Director's Dealing (which is for personal trades) or Share Issue (which is for capital changes).
2025-09-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Handok Inc. titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including the number of shares and the number of recipients. This type of filing is a standard regulatory disclosure regarding capital structure and employee compensation instruments, which falls under the 'Regulatory Filings' (RNS) category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2025-09-16 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and methods of the company's disposal of its own shares. According to the provided definitions, reports regarding the company buying back or selling its own shares are classified as 'Transaction in Own Shares' (POS).
2025-08-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.